Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Revenue

Daehan Nupharm had revenue of 55.97B KRW in the quarter ending June 30, 2026, with 12.22% growth. This brings the company's revenue in the last twelve months to 211.48B, up 4.95% year-over-year. In the year 2025, Daehan Nupharm had annual revenue of 202.40B with 0.11% growth.

• Revenue (ttm): 211.48B
• Revenue Growth: +4.95%
• P/S Ratio: 0.37
• Revenue / Employee: 927.56M
• Employees: 228
• Market Cap: 78.46B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	202.40B	214.78M	0.11%
Dec 31, 2024	202.19B	-2.04B	-1.00%
Dec 31, 2023	204.22B	6.27B	3.16%
Dec 31, 2022	197.96B	31.37B	18.83%
Dec 31, 2021	166.59B	17.29B	11.58%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error